Eric and Sally’s Story From Diagnosis to CAR T

Eric, his wife and care partner Sally, and Eric’s oncologist, Omar Castaneda Puglianini, MD, discuss Eric’s multiple myeloma diagnosis and treatment journey. Upon his first relapse, he decided that CAR T therapy was right for him, as he wanted to maintain his active lifestyle. Eric and Sally also describe the support they’ve received from their healthcare team throughout the course of treatment. Additionally, Dr. Castaneda Puglianini clears up some misconceptions about CAR T therapy, such as concerns related to patient eligibility and post-treatment recovery.

Topics covered:

How to approach the decision-making process in relapsed/refractory multiple myeloma
Receiving support from family and healthcare providers
Clearing up common misconceptions related to CAR T therapy

MORE TREATMENT PERSPECTIVES IN MULTIPLE MYELOMA:

Spotlight on CAR-T Care Partners

Tony and his best friend, Michael, discuss Tony’s journey with CAR-T therapy and the network of care partners who provided support during his journey. Michael and Tony share wisdom on identifying care partners within your support network, as well as helpful financial resources for CAR-T recipients and their care partners to aid them in their journey.

Tony’s Journey After CAR-T

Tony, who underwent CAR-T therapy for his multiple myeloma, shares his recovery experience following his treatment and compares this recovery to that of his previous treatments. Tony’s oncologist, Dr. Peter Voorhees, provides guidance and advice for patients with multiple myeloma seeking financial and travel-related resources for CAR-T therapy.

Tony’s Story—Diagnosis and Treatment Decision Making

Tony, who was diagnosed with multiple myeloma in 2013, and his oncologist, Dr. Peter Voorhees, discuss Tony’s story. Tony shares navigating his diagnosis and Dr. Voorhees emphasizes the importance of early detection. Later, the two discuss Tony’s discovery and exploration of CAR-T therapy as a possible treatment for his disease.